Login / Signup

Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy.

Lei JiGe SongMin XiaoXi ChenQing LiJiayu WangYing FanYang LuoQiao LiShanshan ChenZongbi YiBinghe XuPin Zhang
Published in: Thoracic cancer (2024)
Subdivision of the M1 and prognostic stage could serve as a supplement to the current staging guidelines for dnMBC and guide locoregional treatment.
Keyphrases
  • metastatic breast cancer
  • lymph node
  • clinical practice
  • mesenchymal stem cells
  • bone marrow
  • replacement therapy
  • cell therapy